VEQTOR
Personalized Solutions to Achieve Compliance

One of the biggest challenges in the pharmaceutical arena is the ongoing global harmonization— continuously facing a multiplicity of regulations across different regions and countries. Oftentimes those regulations are not aligned and require a deeper understanding of underlying causes and effects to interpret them correctly and apply them effectively into an organization’s existing systems. Focusing on these elements, VEQTOR has developed personalized and value driven solutions for compliance requirements, which enable organizations to build quality products for the safety of patients at a low cost. “We develop unique customized solutions that can enable pharmaceutical industry to meet and achieve regulatory compliance, approvals, and critical business objectives,” says Martin Radecki, Sr. Partner and Managing Director, VEQTOR. Headquartered in La Grange, IL, VEQTOR’s engineering, IT, quality, validation and regulatory professionals, auditors, and project managers are experts in operating successfully within heavily regulated environments. While adhering to FDA’s exacting standards and requirements, VEQTOR makes an immediate and positive impact on the industry’s compliance and regulatory requirements.

“We believe in the mantra of reducing ‘Total Cost of Quality’ by tailoring our solutions based on the operations model and culture of clients,” underscores Chris Tydus, Sr. Partner and Managing Director, VEQTOR. VEQTOR understands the unique challenges of today’s pharmaceutical, biotechnical, and medical device companies, and brings compliance ready and relevant technologies that are level with today’s changing regulations. VEQTOR’s consulting, technical, and validation services give pharmaceutical and allied companies fast access to the right consultants with cutting-edge knowledge, skills, and the expertise and attention to detail that organizations’ need to remain compliant. With customized solutions and processes, the company completes projects and achieves milestones cost-effectively and accurately while ensuring maximum compliance. “We concentrate on our client’s top priorities and accordingly offer resources and manpower to achieve their core business objectives,” adds Radecki.

VEQTOR’s consultants are experts in managing business critical initiatives by maximizing productivity and reducing total cost to stay on time and within budget. “For every client, we develop targeted solutions and oversee their implementation, synchronization, and process improvements,” highlights Radecki. “Every step of the way, we support our clients with the solutions they need from assessment to implementation and product launches.”
VEQTOR offers consulting services and technical solutions for a wide array of products, technologies, and manufacturing platforms. “We support all stages of the product and process lifecycle; from development, transfer, and validation through continuous monitoring and improvement,” says Tydus. With deliberate planning, thoughtful execution on a foundation of regulatory requirements, adherence to guidelines, science, and innovative engineering, VEQTOR improves the sustainability of its client’s validation approach. “Our validation consultants are meticulously selected based on industry experience, background, and adroitness to ensure the highest level of familiarity with a particular technology, product, and regulatory requirements,” adds Radecki. For pharmaceutical organizations of all sizes, VEQTOR brings the right people and tools to meet deadlines and cost demands.

“At VEQTOR, we believe that to drive customer satisfaction, we must foster a winning culture based on our employee’s engagement and strong values,” says Radecki. “We encourage employee ownership that spurs initiative and responsibility, which also leads to continuous improvement of our business processes and services.” Building a collaborative environment within the company has enabled VEQTOR to build a strong relationship with its clients and partners. In the coming days, VEQTOR will be seen implementing viable strategies to maintain its focus on the mutual benefit of patients and the industry.